The life sciences, and in particular the pharmaceutical industry, are faced with an unprecedented volume of data to manage and analyze. The cloud offers tools for pharmaceutical companies to manage this complexity and improve operations. See below for a few of the applications transforming the pharmaceutical industry today.

Pharmaceutical Industry Use Cases

Expedite Pharmaceutical Research and Development

With cloud-hosted infrastructure in place, pharmaceutical companies are able to draw data insights more rapidly than with traditional, on-premise infrastructure. Ultimately, this can lead to advancements in research and development (R&D).

Leverage Global Talent for Pharmaceutical Research and Development

The use case for cloud in pharma expands beyond R&D. Pharmaceutical companies can enhance collaboration and draw from a global talent pool by leveraging the cloud’s agile deployment model, through which new users can be spun up in a very short period of time.

Adhere to Shrinking Pharma Budgets

All these factors are compounded with the widespread phenomenon of budget reduction across pharmaceutical companies. In a Forbes article, it was cited that US investment in pharmaceutical R&D declined by $12.9 billion from 2007 to 2012. Pharmaceutical companies faced with declining budgets can benefit from savings over on-prem solutions and the cloud’s operational expense costing model.

Pharmaceutical Application Publishing

Considering the central role of application use in the pharmaceutical industry, another salient cloud use is in the realm of application publishing. With a virtualized solution, pharmaceutical companies are able to avoid compatibility issues and run Line of Business (LOB) apps that require multiple instances or versions.

One pharmaceutical company – Dermatran – a group of compounding pharmacies– leverages our application publishing service, dinApp, to deploy multiple instances of the Compounder application simultaneously. They cite dinApp’s desktop integration, HIPAA/PCI compliance support, and inherent security measures as having facilitated deployment of the Compounder application to its users in four geographically dispersed office locations.

You Might Also Like: